Produkty 38395-02-7

CAS 38395-02-7 występuje w naszej ofercie pod nazwami: caudatin, Caudatin/ 99.88% (existing batch purity), caudatin, 99.90% ,, 99.90% ,, Caudatin (Standard), Caudatin, 99.95%. Oferty producentów: GLPBio, TargetMol, Chemat, MedChemExpress. Dostępne opakowania: 20mg, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 500mg.

caudatin
GLPBio
  • opakowanie: 20mg
  • Warianty: 1
od 1444,21
Zobacz produkt
Caudatin/ 99.88% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 724,90
Zobacz produkt
caudatin, 99.90% ,, 99.90% ,
Chemat
  • opakowanie: 20mg, 1mg
  • Warianty: 2
od 453,20
Zobacz produkt
Caudatin (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Caudatin, 99.95%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 1 mg
  • Warianty: 3
od 616,91
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate (CAS 38395-02-7) to związek chemiczny o wzorze sumarycznym C28H42O7 i masie molowej 490.6 g/mol. Nazwa systematyczna IUPAC: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate. InChIKey: VWLXIXALPNYWFH-UXGQNDOZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H42O7
Masa molowa490.6 g/mol
Nazwa IUPAC[(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate
InChIKeyVWLXIXALPNYWFH-UXGQNDOZSA-N
SMILESCC(C)/C(=C/C(=O)O[C@@H]1C[C@@H]2[C@]3(CC[C@@H](CC3=CC[C@]2([C@@]4([C@]1([C@@](CC4)(C(=O)C)O)C)O)O)O)C)/C

Dane obliczone przez PubChem (NCBI)

Synonimy: Caudatin, Caudatin (Standard), orb1304488, orb3139891
Izomery (ten sam wzór sumaryczny)
methyl (4R)-4-[(4S,5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C28H42O7
(2R)-5-(hydroxymethyl)-4-methyl-2-[(1S)-1-[(4S,5R,6S,8S,9S,10R,13S,14S,17R)-4,5,6-trihydroxy-10,13-dimethyl-1-oxo-3,4,6,7,8,9,11,12,14,15,16,17-dodecahydro-2H-cyclopenta[a]phenanthren-17-yl]ethyl]-2,3-dihydropyran-6-one C28H42O7
[(3S,8R,9S,10R,11S,12S,13S,14S,17S)-17-acetyl-11-acetyloxy-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-yl] 3-methylbutanoate C28H42O7
5-[(1R)-1-[(1S,4R,4aR,6R,8aS)-4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H42O7
5-[1-[(1S,4R,4aR,6R,8aS)-4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-1,2,3,4a,5,6,7,8-octahydronaphthalen-1-yl]-3-methylbutyl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde C28H42O7